Search research articles
Contact Us
Filters
Showing results (91-100 of 123) with videos related to
Page
of 13
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 26, 2022
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal
Fabien Rollot, Justine Couturier, Romain Casey, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 18, 2025
Pregnancy and birth outcomes in women with multiple sclerosis: Comparison of the RESPONSE study to the general French population
Elisabeth Maillart, Fabien Rollot, Emmanuelle Leray, et al.
Neurology
|
July 11, 2024
Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of MOGAD in Adults: The MOGADOR2 Study
Romain Deschamps, Jessica Guillaume, Jonathan Ciron, et al.
European Journal of Neurology
|
March 2, 2021
Untreated patients with multiple sclerosis: A study of French expert centers
Xavier Moisset, Audrey-Anne Fouchard, Bruno Pereira, et al.
Journal of Alzheimer'S Disease : JAD
|
December 21, 2012
C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing
Isabelle Le Ber, Agnès Camuzat, Lena Guillot-Noel, et al.
Multiple Sclerosis and Related Disorders
|
May 14, 2026
External validation and improvement of an algorithm that identifies multiple sclerosis relapses in the French national healthcare claims database
Laure Carcaillon-Bentata, Abdelilah Abouelfath, Séverine Lignot-Maleyran, et al.
Neurology
|
November 6, 2016
CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy
Béatrice Pignolet, Nicholas Schwab, Tilman Schneider-Hohendorf, et al.
Neurology
|
September 25, 2024
Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis: A Multicenter Real-Life Study
Marion Hay, Fabien Rollot, Romain Casey, et al.
JAMA Network Open
|
October 11, 2021
Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome
Christine Lebrun-Frénay, Fabien Rollot, Lydiane Mondot, et al.
JAMA Neurology
|
September 4, 2019
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France
Sandra Vukusic, Fabien Rollot, Romain Casey, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 123) with videos related to
Sort By:
Page
of 13
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 26, 2022
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal
Fabien Rollot, Justine Couturier, Romain Casey, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 18, 2025
Pregnancy and birth outcomes in women with multiple sclerosis: Comparison of the RESPONSE study to the general French population
Elisabeth Maillart, Fabien Rollot, Emmanuelle Leray, et al.
Neurology
|
July 11, 2024
Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of MOGAD in Adults: The MOGADOR2 Study
Romain Deschamps, Jessica Guillaume, Jonathan Ciron, et al.
European Journal of Neurology
|
March 2, 2021
Untreated patients with multiple sclerosis: A study of French expert centers
Xavier Moisset, Audrey-Anne Fouchard, Bruno Pereira, et al.
Journal of Alzheimer'S Disease : JAD
|
December 21, 2012
C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing
Isabelle Le Ber, Agnès Camuzat, Lena Guillot-Noel, et al.
Multiple Sclerosis and Related Disorders
|
May 14, 2026
External validation and improvement of an algorithm that identifies multiple sclerosis relapses in the French national healthcare claims database
Laure Carcaillon-Bentata, Abdelilah Abouelfath, Séverine Lignot-Maleyran, et al.
Neurology
|
November 6, 2016
CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy
Béatrice Pignolet, Nicholas Schwab, Tilman Schneider-Hohendorf, et al.
Neurology
|
September 25, 2024
Anti-CD20 Therapies in Drug-Naive Patients With Primary Progressive Multiple Sclerosis: A Multicenter Real-Life Study
Marion Hay, Fabien Rollot, Romain Casey, et al.
JAMA Network Open
|
October 11, 2021
Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome
Christine Lebrun-Frénay, Fabien Rollot, Lydiane Mondot, et al.
JAMA Neurology
|
September 4, 2019
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France
Sandra Vukusic, Fabien Rollot, Romain Casey, et al.
Page
of 13